Literature DB >> 12095830

Bilateral optic disk edema and blindness as initial presentation of acute lymphocytic leukemia.

George L Mayo1, John E Carter, Stuart J McKinnon.   

Abstract

PURPOSE: To report bilateral optic disk edema and blindness as the unusual initial presentation of acute lymphocytic leukemia (ALL) in an adult.
METHODS: A 19-year-old man presented with a history of headaches, back pain, and 10 days of worsening vision that progressed to blindness. Ocular examination revealed light perception acuity in the right eye and no light perception in the left eye. Fundus examination revealed bilateral profound optic disk edema, tortuous vessels, and retinal hemorrhages. Acute lymphocytic leukemia was diagnosed with complete blood count and bone marrow biopsy. Head computed tomography and magnetic resonance imaging, were normal. Lumbar puncture revealed normal opening pressure. Ocular ultrasonography showed bilateral optic nerve enlargement.
DESIGN: Interventional case report and literature review.
RESULTS: The presumptive diagnosis of leukemic infiltration of the optic nerves was made, and urgent radiotherapy, intrathecal methotrexate, and intravenous daunorubicin were instituted. Visual acuity improved to hand motions in the right eye.
CONCLUSIONS: Acute lymphocytic leukemia can rarely present in adults as visual changes due to leukemic optic nerve infiltration. Radiation treatment should be considered as an urgent treatment modality for this rare condition.

Entities:  

Mesh:

Year:  2002        PMID: 12095830     DOI: 10.1016/s0002-9394(02)01465-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  An adolescent with suspected intracranial hypertension - ALL is not what it seems.

Authors:  Asgeir Store Jakola; Sasha Gulati
Journal:  Childs Nerv Syst       Date:  2012-01-28       Impact factor: 1.475

Review 2.  Extramedullary manifestations in acute lymphoblastic leukemia in children: a systematic review and guideline-based approach of treatment.

Authors:  Mahdi Shahriari; Nader Shakibazad; Sezaneh Haghpanah; Khadijeh Ghasemi
Journal:  Am J Blood Res       Date:  2020-12-15

3.  Rapid vision loss in a 15-year-old boy.

Authors:  V K Mittal; M W Ko; J Chang
Journal:  Br J Radiol       Date:  2011-06       Impact factor: 3.039

4.  [Bilateral decreased visual acuity and progressively decreasing physical fitness].

Authors:  D Duwendag; J Roider; J Hillenkamp
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

Review 5.  The optic nerve head in acquired optic neuropathies.

Authors:  Evelyn C O'Neill; Helen V Danesh-Meyer; Paul P Connell; Ian A Trounce; Michael A Coote; David A Mackey; Jonathan G Crowston
Journal:  Nat Rev Neurol       Date:  2010-03-09       Impact factor: 42.937

6.  Case report: optic disc edema without hydrocephalus in acoustic neuroma.

Authors:  Joseph Grainger; Palitha S Dias
Journal:  Skull Base       Date:  2005-02

7.  Peripheral ulcerative keratitis with bilateral optic nerve involvement as an initial presentation of acute lymphocytic leukemia in an adult.

Authors:  Bhavna Chawla; Prakashchand Agarwal; Radhika Tandon; Jeewan S Titiyal
Journal:  Int Ophthalmol       Date:  2007-11-16       Impact factor: 2.031

8.  Enhanced depth imaging optical coherence tomography of precursor cell leukemic choroidopathy before and after chemotherapy.

Authors:  Murtaza K Adam; John D Pitcher; Carol L Shields; Joseph I Maguire
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

9.  Central retinal vein occlusion as first manifestation of relapse in acute lymphoblastic leukemia.

Authors:  Flávia Kessler Borges; Júlia Biegelmeyer; Samantha Thifani Alrutz Barcelos; Raquel Cristine Breunig
Journal:  Rev Bras Hematol Hemoter       Date:  2015-04-14

10.  Ischaemic optic neuropathy induced sudden blindness as an initial presentation of acute lymphoblastic leukemia.

Authors:  Tamojit Chaudhuri; Somnath Roy; Parag Roy
Journal:  Indian J Med Paediatr Oncol       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.